Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Men, Women & Medical Differences in Axial Spondyloarthropathy

Ruth Jessen Hickman, MD  |  Issue: December 2019  |  October 24, 2019

“I think it would be helpful to stratify and pool the data that we already have for these drugs and look into the differences between men and women,” says Dr. van der Horst-Bruinsma. “I think we have to be careful not to say, ‘We did a multi-logistic regression analysis, and it doesn’t come out,’ because if the population of women is too low, you will not find significant difference. But if you have sufficient data on men and women, you might find differences.”


Ruth Jessen Hickman, MD, is a graduate of the Indiana University School of Medicine. She is a freelance medical and science writer living in Bloomington, Ind.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Lee W, Reveille JD, Weisman MH. Women with ankylosing spondylitis: A review. Arthritis Rheum. 2008 Mar 15;59(3):449–454.
  2. Purnamawati K, Ong JA, Deshpande S, et al. The importance of sex stratification in autoimmune disease biomarker research: A systematic review. Front Immunol. 2018 Jun 4;9:1208.
  3. Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018 Oct 4;9:2279.
  4. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009 Jun;68(6):777–783.
  5. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984 Apr;27(4):361–368.
  6. Malaviya AN, Rawat R, Agrawal N, et al. The nonradiographic axial spondyloarthritis, the radiographic axial spondyloarthritis, and ankylosing spondylitis: The tangled skein of rheumatology. Int J Rheumatol. 2017;2017:1824794.
  7. Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Gender Differences in axial spondyloarthritis: Women are not so lucky. Curr Rheumatol Rep. 2018 May 12;20(6):35.
  8. Polley HF, Slocumb CH. Rheumatoid spondylitis: A study of 1,035 cases. Ann Intern Med. 1947 Feb;26(2):240–249.
  9. Neuenschwander R, Ciurea A. Gender differences in axial spondyloarthritis. World J Rheumatol. 2014 Nov 12;4(3):35–43.
  10. van der Horst-Bruinsma IE, Zack DJ, Szumski A, et al. Female patients with ankylosing spondylitis: Analysis of the impact of gender across treatment studies. Ann Rheum Dis. 2013 Jul;72(7):1221–1224.
  11. Gracey E, Yao Y, Green B, et al. Sexual dimorphism in the Th17 signature of ankylosing spondylitis. Arthritis Rheumatol. 2016 Mar;68(3):679–689.
  12. Lee W, Reveille JD, Davis JC Jr, et al. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2006 May;66(5):633–638.
  13. Braun J. Axial spondyloarthritis including ankylosing spondylitis. Rheumatology (Oxford). 2018 Nov;57(Suppl 6):vi1–vi3.
  14. Jovani V, Blasco-Blasco M, Pascual E, et al. Challenges to conquer from the gender perspective in medicine: The case of spondyloarthritis. PLoS One. 2018 Oct 12;13(10):e0205751.
  15. Jovaní V, Blasco-Blasco M, Ruiz-Cantero MT, et al. Understanding how the diagnostic delay of spondyloarthritis differs between women and men: A systematic review and metaanalysis. J Rheumatol. 2017 Feb;44(2):174–183.
  16. Hebeisen M, Neuenschwander R, Scherer A, et al. Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis: Data from a Swiss cohort. J Rheumatol. 2018 Apr;45(4):506–512.
  17. Rusman T, Ten Wolde S, Euser SM, et al. Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: A retrospective cohort study in daily practice. Int J Rheum Dis. 2018 Apr;21(4):836–842.
  18. Ibáñez Vodnizza SE, Nurmohamed MT, Visman IM, et al. Fat mass lowers the response to tumor necrosis factor-α blockers in patients with ankylosing spondylitis. J Rheumatol. 2017 Sep;44(9):1355–1361.
  19. Tannenbaum C, Day D, Matera Alliance. Age and sex in drug development and testing for adults. Pharmacol Res. 2017 Jul;121:83–93.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditions Tagged with:Ankylosing Spondylitisaxial spondyloarthritis (SpA)Gendersexual dimorphism

Related Articles

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

    November 18, 2022

    PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…

    Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

    May 8, 2012

    Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

    “A Common Language for Spondyloarthritis”

    December 1, 2010

    ASAS fills a niche, changes dogma with consensus approach

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences